報價延遲最少15分鐘:2026/02/12 05:26 EST
盤前時段
|
||||
|
-- 
|
|
|
常規時段 (已結束)
|
|
|
|
|
||||||||||||
|
|
|
|
|
133.14
|
|
|
| 價值評估 |
|
盈利(現時/預測)
7.42/14.80
|
|
企業價值
14.57B
|
| 資產負債 |
|
每股賬面淨值
122.25
|
| 現金流量 |
|
現金流量率
0.10
|
| 損益表 |
|
收益
1.76B
|
|
每股收益
104.98
|
|
同行比較
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland. |
